The president said he would impose a tariff of 100 percent on certain brand-name drugs. Here’s what we know so far.
Author: Rebecca Robbins
A Glaxo antibody drug is restricted in the U.S. Northeast as an Omicron subvariant spreads.
The move leaves doctors in the region with one less option to treat high-risk Covid patients.
FDA Rejects India-Made Bharat Biotech Vaccine For Those Under 18
The vaccine, made by Bharat Biotech, is widely used in India. It has not been tested in the U.S., which has not authorized it for any age groups.
F.D.A. Approves Remdesivir for Patients Not Hospitalized
The treatment must be given via intravenous infusion over three consecutive days, generally at a hospital or clinic.
F.D.A. Authorizes Eli Lilly Antibody Treatment for Youngest Covid Patients
Doctors have a new option for the youngest patients who are vulnerable to the worst outcomes from Covid.
Merck Says Its Covid Pill Is Less Effective in a Final Analysis
The drug, molnupiravir, reduced the risk of hospitalization and death in high-risk Covid patients by 30 percent. An earlier analysis had found a 50 percent reduction.
Moderna to Sell Up to 110 Million Covid Vaccine Doses to African Countries
Moderna’s shots have previously gone almost entirely to wealthier countries.
AstraZeneca Booster Shot Lifts Immune Response, Study Finds
A third shot of the vaccine lifted immune response in volunteers who had already received two.
Covax to Receive 200 Million Johnson & Johnson Covid Doses
The program’s struggles are one factor among many in the growing gap in vaccination coverage between the world’s rich and poor.
Study results strengthen the case for using Regeneron’s antibody cocktail in high-risk Covid patients.
The treatment sharply cut the risk of hospitalization and death in a large clinical trial, the drug maker announced.